TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating and financial results for the three and six months ended June 30, 2009. For the second quarter of 2009, the net loss attributable to common stockholders declined 9% to $7.1 million, or $0.06 per share, compared with a net loss attributable to common stockholders of $7.8 million, or $0.15 per share, for the second quarter of 2008. For the six months ended June 30, 2009, the net loss attributable to common stockholders was $29.6 million, or $0.27 per share, compared with a net loss attributable to common stockholders of $13.8 million, or $0.28 per share, for the six months ended June 30, 2008.
